Robert W. Adams - 01 Jul 2021 Form 4 Insider Report for Diffusion Pharmaceuticals Inc. (CRVO)

Role: Director
Signature: /s/ William R. Elder, as attorney-in-fact for the Reporting Person
Issuer symbol: CRVO
Transactions as of: 01 Jul 2021
Net transactions value: $0
Form type: 4
Filing time: 06 Jul 2021, 21:41:56 UTC
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DFFN	Stock Option (Right to Buy)	Award	$0	+83,300		$0.000000	83,300	01 Jul 2021	Common Stock	83,300	$0.7200	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares underlying the options will vest in 12 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a 12-month period beginning July 1, 2021.